2018 annual financial data
Corbus Pharmaceuticals Holdings 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -623.51%.
Operating income was -56,747,707 USD and net income was -55,672,139 USD.
Operating cash flow was -30,067,255 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,822,272 USD
- Operating income
- -56,747,707 USD
- Net income
- -55,672,139 USD
- Operating cash flow
- -30,067,255 USD